Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | JAK2 | O60674 | 2/20 | 0.57 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.57 |
| ▸ | CAMK2D | Q13557 | 2/20 | 0.56 |
| ▸ | ABL1 | P00519 | 4/20 | 0.55 |
| ▸ | PDGFRB | P09619 | 4/20 | 0.55 |
| ▸ | BCR | P11274 | 4/20 | 0.55 |
| ▸ | PDGFRA | P16234 | 4/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.53 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.53 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.53 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.53 |
| ▸ | JAK3 | P52333 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5470852 | 0.90 | ADORA1 (0.69) | JAK2ADORA1CAMK2DABL1PDGFRB | |
| SCHEMBL5472823 | 0.86 | ADORA1 (0.57) | JAK2ADORA1CAMK2DABL1PDGFRB | |
| SCHEMBL5472470 | 0.86 | ADORA3 (0.65) | JAK2ADORA1CAMK2DABL1PDGFRB | |
| SCHEMBL5472892 | 0.86 | JAK2 (0.76) | CYP2C19JAK2ADORA1CAMK2DMEN1 | |
| SCHEMBL5472976 | 0.86 | PIK3CA (0.59) | JAK2ADORA1CAMK2DNPC1RAB9A | |
| SCHEMBL26884030 | 0.85 | TLR7 (0.54) | DYRK1ACYP1A2CYP3A4CYP2C19JAK2 | |
| SCHEMBL5469085 | 0.83 | ABL1 (0.57) | JAK2ADORA1CAMK2DABL1PDGFRB | |
| SCHEMBL5465350 | 0.83 | SIRT2 (0.68) | DYRK1AJAK2ADORA1CAMK2DABL1 | |
| SCHEMBL5470733 | 0.82 | MEN1 (0.56) | CYP2C19JAK2ADORA1CAMK2DABL1 | |
| SCHEMBL5462749 | 0.80 | SCN10A (0.54) | JAK2ADORA1CAMK2DABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070099938-A1 | Antistress drug and medical use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-05-03 | — | — | US | disclosed |
| EP-1679309-A1 | ANTISTRESS DRUG AND MEDICAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099938-A1 | Antistress drug and medical use thereof | NPSR1, MC2R, SRR | DYRK1A 600/4885CYP1A2 500/4885CYP3A4 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.